FindTrial
Sign In

Application study of brachytherapy treatment planning system (TPS) in early diagnosis and post-operation follow-up of prostate cancer

Application study of brachytherapy treatment planning system (TPS) in early diagnosis and post-operation follow-up of prostate cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-16010040
Enrollment
Unknown
Registered
2016-11-29
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Observation group: brachytherapy treatment planning system
Control group:Traditional treatment

Sponsors

Subei People's Hospital of Jiangsu province/ College of Clinical Medicine, Yangzhou University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Prostate specific antigen <10ug/L; Imaging suspicious nodules; Aged 60 to 75 years.

Exclusion criteria

Exclusion criteria: Past clear history of prostate cancer; Severe urinary tract infection; Severe cardiovascular and cerebrovascular diseases or abnormal blood coagulation

Design outcomes

Primary

MeasureTime frame
Overall survival;PSA progression-free survival;—

Secondary

MeasureTime frame
Positive rate;—

Countries

China

Contacts

Public ContactXue-fei Ding

Subei People's Hospital of Jiangsu province/ College of Clinical Medicine, Yangzhou University

xuefeid@126.com+86 18051061234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026